Blocking α4β7 integrin binding to SIV does not improve virologic control
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blocking α4β7 integrin binding to SIV does not improve virologic control
Authors
Keywords
-
Journal
SCIENCE
Volume 365, Issue 6457, Pages 1033-1036
Publisher
American Association for the Advancement of Science (AAAS)
Online
2019-09-06
DOI
10.1126/science.aaw7765
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7
- (2018) Sakaorat Lertjuthaporn et al. PLoS Pathogens
- Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge
- (2018) Hugh C. Welles et al. PLoS Pathogens
- Integrin α4β7Blockade Preferentially Impacts CCR6+Lymphocyte Subsets in Blood and Mucosal Tissues of Naive Rhesus Macaques
- (2017) Giulia Calenda et al. JOURNAL OF IMMUNOLOGY
- Early treatment of SIV+ macaques with an α4β7 mAb alters virus distribution and preserves CD4+ T cells in later stages of infection
- (2017) P J Santangelo et al. Mucosal Immunology
- HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
- (2016) Johannes F. Scheid et al. NATURE
- Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
- (2016) Katharine J. Bar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Envelope residue 375 substitutions in simian–human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques
- (2016) Hui Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sustained virologic control in SIV+ macaques after antiretroviral and 4 7 antibody therapy
- (2016) S. N. Byrareddy et al. SCIENCE
- Current status and prospects of HIV treatment
- (2016) Tomas Cihlar et al. Current Opinion in Virology
- Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability
- (2016) Rosemarie D. Mason et al. PLoS Pathogens
- HIV-1 Fitness Cost Associated with Escape from the VRC01 Class of CD4 Binding Site Neutralizing Antibodies
- (2015) Rebecca M. Lynch et al. JOURNAL OF VIROLOGY
- Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
- (2015) Marina Caskey et al. NATURE
- Generation and characterization of a SIVmac239 clone corrected at four suboptimal nucleotides
- (2015) Christine M Fennessey et al. Retrovirology
- Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
- (2015) Rebecca M. Lynch et al. Science Translational Medicine
- Cryptic Determinant of α4β7 Binding in the V2 Loop of HIV-1 gp120
- (2014) Boonrat Tassaneetrithep et al. PLoS One
- HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells
- (2008) James Arthos et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started